We Should at Least Be Able to Design Molecules That Dock Well

Abstract

Designing compounds with desired properties is a key element of the drug discovery process. However, measuring progress in the field has been challenging due to the lack of realistic retrospective benchmarks, and the large cost of prospective validation. To close this gap, we propose a benchmark based on docking, a popular computational method for assessing molecule binding to a protein. Concretely, the goal is to generate drug-like molecules that are scored highly by SMINA, a popular docking software. We observe that popular graph-based generative models fail to generate molecules with a high docking score when trained using a realistically sized training set. This suggests a limitation of the current incarnation of models for de novo drug design. Finally, we propose a simplified version of the benchmark based on a simpler scoring function, and show that the tested models are able to partially solve it. We release the benchmark as an easy to use package available at https://github.com/cieplinski-tobiasz/smina-docking-benchmark. We hope that our benchmark will serve as a stepping stone towards the goal of automatically generating promising drug candidates.

arXiv commentPublished in Journal of Chemical Information and Modeling

References in corpus (13)

• Auto-Encoding Variational Bayes
• Automatic chemical design using a data-driven continuous representation of molecules
• GuacaMol: Benchmarking Models for De Novo Molecular Design
• Junction Tree Variational Autoencoder for Molecular Graph Generation
• Deep learning for molecular design - a review of the state of the art
• Autonomous discovery in the chemical sciences part II: Outlook
• Mol-CycleGAN - a generative model for molecular optimization
• Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development
• Sample Efficiency Matters: A Benchmark for Practical Molecular Optimization
• We Should at Least Be Able to Design Molecules That Dock Well
• Latent Molecular Optimization for Targeted Therapeutic Design
• 3DLinker: An E(3) Equivariant Variational Autoencoder for Molecular Linker Design
• JANUS: Parallel Tempered Genetic Algorithm Guided by Deep Neural Networks for Inverse Molecular Design

Cited by in corpus (1)

• We Should at Least Be Able to Design Molecules That Dock Well